Evidence map›Paper›PMID 31614577›Full record

ReviewAntioxidants (Basel, Switzerland)2019

Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways.

J Catharina Duvigneau, Harald Esterbauer, Andrey V Kozlov

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. A FunctionalAntioxidants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Heme oxygenase-1 and malaria pathogenesis.Frontiers in immunology · 2026
    Review
  8. Article
  9. Article
  10. Sex-specific glomerular filtration rate changes in response to acute hemoglobin exposure.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Synergistic Antioxidant Effects of C3G-EnrichedInternational journal of molecular sciences · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J Catharina DuvigneauInstitute for Medical Biochemistry, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, Austria. catharina.duvigneau@vetmeduni.ac.at.ORCID 0000-0002-2433-3120
Harald EsterbauerDepartment of Laboratory Medicine, Medical University of Vienna, 1210 Vienna, Austria. harald.esterbauer@meduniwien.ac.at.
Andrey V KozlovLudwig Boltzmann Institute for Experimental and Clinical Traumatology, 1200 Vienna, Austria. andrey.kozlov@trauma.lbg.ac.at.ORCID 0000-0002-0834-4997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The heme oxygenase (HO) system is essential for heme and iron homeostasis and necessary for adaptation to cell stress. HO degrades heme to biliverdin (BV), carbon monoxide (CO) and ferrous iron. Although mostly beneficial, the HO reaction can also produce deleterious effects, predominantly attributed to excessive product formation. Underrated so far is, however, that HO may exert effects additionally via modulation of the cellular heme levels. Heme, besides being an often-quoted generator of oxidative stress, plays also an important role as a signaling molecule. Heme controls the anti-oxidative defense, circadian rhythms, activity of ion channels, glucose utilization, erythropoiesis, and macrophage function. This broad spectrum of effects depends on its interaction with proteins ranging from transcription factors to enzymes. In degrading heme, HO has the potential to exert effects also via modulation of heme-mediated pathways. In this review, we will discuss the multitude of pathways regulated by heme to enlarge the view on HO and its role in cell physiology. We will further highlight the contribution of HO to pathophysiology, which results from a dysregulated balance between heme and the degradation products formed by HO.

Indexed as

biliverdincarbon monoxidefree hemefree ironheme oxygenaseintracellular signalingoxidative stress

Identifiers

PMID31614577
PMCPMC6827082

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.